Mitochondrial imaging detects early cardiac responses to cancer immunotherapy

Clicks: 4
ID: 323650
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #36 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Cancer therapy-induced cardiotoxicity, particularly that associated with immunotherapy, is hard to diagnose and manage because current methods lack molecular specificity and are unable to detect early cardiac injury. Mitochondrial dysfunction underlies cardiotoxicity from conventional therapy, whereas T-cell infiltration drives immunotherapy-associated myocarditis. [¹⁸F]F-AraG is a PET tracer that allows noninvasive visualization of mitochondrial biogenesis in cardiomyocytes and activated T cells, enabling early detection of cardiotoxicity associated with cancer therapies, including immune checkpoint blockade (Figure 1). Purpose To evaluate whether [¹⁸F]F-AraG PET can serve as an early imaging biomarker of treatment-related mitochondrial alterations in the myocardium. Methods Doxorubicin-treated mice were used to model chemotherapy-induced cardiac injury. Early myocarditis detection was evaluated using [¹⁸F]F-AraG PET/CT in poly I:C–treated and experimental autoimmune myocarditis (EAM) mouse models. To assess the translational potential of [¹⁸F]F-AraG PET for assessment of off-target cardiac effects, 26 healthy subjects underwent PET imaging to establish physiological myocardial uptake. Seven patients with stage III melanoma and ten with advanced NSCLC were scanned before and after one infusion of immunotherapy. Myocardial uptake (SUVmax, SUVmean, SUVtotal) was quantified in the left (LV) and right (RV) ventricles, with regional LV analysis using a 17-segment model. Myocardial tracer uptake was compared with ECG findings in two patients with head and neck (H&N) cancer who had available ECG data. Associations between tracer uptake, mitochondrial DNA content, and PGC-1α expression were evaluated. Results Cardiac [¹⁸F]F-AraG uptake decreased after doxorubicin treatment (6.4 vs 4.5 %ID/cc, p<0.0001) alongside reductions in mitochondrial DNA copy number. In contrast, uptake increased in myocarditis models (poly I:C: 6.4 vs 9.9 %ID/cc, p<0.0001; EAM: 7.2 vs 9.9 %ID/cc, p=0.007) (Figure 1). Healthy human myocardium showed consistent, spatially uniform uptake (SUVmean COV: 11.2% LV, 12.3% RV), with higher LV uptake corresponding to greater mitochondrial content and PGC-1α expression. Previously treated patients with NSCLC demonstrated higher baseline LV uptake than controls (SUVmean 4.27 vs 3.47, p=0.01). Although mean post-immunotherapy changes were modest, >20% ventricular uptake increases occurred in 4/7 melanoma and 4/10 NSCLC patients; focal increases >40% in regional analysis were observed in 3/7 and 3/10 patients, respectively. Altered uptake patterns were associated with ECG abnormalities in patients with H&N. Conclusion [¹⁸F]F-AraG PET detects therapy-associated mitochondrial changes in the myocardium following cancer treatment. These findings support its potential utility as a noninvasive imaging approach for early evaluation of therapy-induced cardiac effects and anti-tumor immunity to guide patient care (Figure 2).
Reference Key
openalex_W4415306383 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hee-Don Chae, Uttam Shrestha, Millie Das, Minal Vasanawala, Deepti Behl, Diwakar Davar, Shyam Srinivas, A. Dimitrios Colevas, John B. Sunwoo, Niko Del Mar, Michele Pierini, Michele Guillen, José García, Negar Omidvari, Nikhil Gupta, Hilda Cabrera, Joseph Blecha, Simon R. Cherry, Henry F. VanBrocklin, Javid J. Moslehi, Youngho Seo, Jelena Levi
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.193
URL
https://doi.org/10.1093/eurheartjsupp/suag097.193
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.